[A trial of the use of the prolonged-action preparation Koldakt from the Natko firm for treating upper respiratory tract diseases in polyclinics].
Rumiantsev
A G
AG
Aldonina
V V
VV
Il'ina
T P
TP
Snitarenko
V Iu
VIu
Biriuchinskaia
I G
IG
Shevaldina
T V
TV
D000328:Adult; D002214:Capsules; D002648:Child; D002744:Chlorpheniramine / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006801:Humans; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D002214:Capsules; D003692:Delayed-Action Preparations; D004338:Drug Combinations; C083542:chlorpheniramine, phenylpropanolamine drug combination; D010665:Phenylpropanolamine; D002744:Chlorpheniramine
Opyt primeneniia preparata prolongirovannogo deĭstviia "Koldakt" firmy "Natko" dlia lecheniia zabolevaniĭ verkhnikh dykhatel'nykh puteĭ v poliklinicheskikh usloviiakh.